ANI Pharmaceuticals | ANIP - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
AbbVie USD 3.84B 205M 2026-09
ANI Pharmaceuticals USD 94.86M 3.2M 2026-09
Aurora Cannabis CAD 40.89M 515K 2026-06
Canopy Growth CAD 33.99M 2.83M 2026-06
Eli Lilly USD 3.12B 305M 2026-09
Emergent BioSolutions USD 182.8M 82.3M 2023-06
Heron Therapeutics USD 23.74M 605K 2025-12
Hikma Pharmaceutical USD 288M 149M 2025-12
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Nektar Therapeutics USD 11.87M 1.7M 2026-03
Novartis USD 3.08B 58M 2026-09
Omeros USD 11.32M 2.48M 2024-09
Perrigo USD 271.7M 3.01B 2026-09
Sun Pharmaceuticals INR 24.89B 637.6M 2025-03
Teva Pharmaceutical Industries USD 1.01B 27M 2026-09